Skip to content
Toggle navigation
About
Who We Are
Our Focus
Leadership
Board
of Directors
Therapeutic Areas
Progressive
Pulmonary Disease
Malabsorption
Syndromes
Patient Focus
Cystic Fibrosis
Other Rare
Disease Areas
Product Development
News & Publications
Press Releases
Publications
& Abstracts
Contact
About
Who We Are
Our Focus
Leadership
Board
of Directors
Therapeutic Areas
Progressive
Pulmonary Disease
Malabsorption
Syndromes
Patient Focus
Cystic Fibrosis
Other Rare
Disease Areas
Product Development
News & Publications
Press Releases
Publications
& Abstracts
Contact
News &
Publications
Press Releases
Publications
& Abstracts
< Back to Press Releases
October 11, 2018
BusinessWire: Synspira Receives U.S. FDA Orphan Designation
Read on
BusinessWire
Toggle navigation
Toggle navigation